SCHEMBL4081554

SCHEMBL4081554

CCOC(=O)/C(=N\Nc1ccccc1)C(=O)c1ccccc1F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 6/20 0.52
LMNA P02545 3/20 0.52
ALDH1A1 P00352 4/20 0.51
NPSR1 Q6W5P4 2/20 0.51
HPGD P15428 1/20 0.51
ATM Q13315 1/20 0.51
SMN1; SMN2 Q16637 4/20 0.47
KDM4E B2RXH2 4/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
MAPT P10636 4/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
TDP1 Q9NUW8 2/20 0.44
RECQL P46063 1/20 0.44
KDR P35968 1/20 0.44
KYAT1 Q16773 2/20 0.42
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4081557 1.00 GAA (0.52) GAALMNAALDH1A1NPSR1HPGD
SCHEMBL16681749 0.85 ABCB1 (0.46) GAALMNAALDH1A1NPSR1HPGD
SCHEMBL16681747 0.85 ABCB1 (0.46) GAALMNAALDH1A1NPSR1HPGD
SCHEMBL23348046 0.83 GAA (0.58) GAALMNAALDH1A1NPSR1HPGD
SCHEMBL4551177 0.82 MAPT (0.48) GAALMNAALDH1A1SMN1; SMN2KDM4E
SCHEMBL4551178 0.82 MAPT (0.48) GAALMNAALDH1A1SMN1; SMN2KDM4E
SCHEMBL24584758 0.81 CES2 (0.49) GAALMNAALDH1A1NPSR1SMN1; SMN2
SCHEMBL3716151 0.80 CES2 (0.47) GAALMNAALDH1A1NPSR1HPGD
SCHEMBL3716153 0.80 CES2 (0.47) GAALMNAALDH1A1NPSR1HPGD
SCHEMBL6786789 0.80 GAA (0.60) GAALMNAALDH1A1NPSR1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009053799-A1 NOVEL CANNABINOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESS FOR THEIR PREPARATION GLENMARK PHARMACEUTICALS, S.A. (US) 2009-04-30 WO disclosed